ViraTherapeutics
ViraTherapeutics develops highly potent cancer-destroying (oncolytic) viruses that are effective in a broad range of different cancers.
- Stage Prototype Ready
- Industry Biotechnology
- Location Innsbruck, Austria
- Currency EUR
- Employees 3
Company Summary
ViraTherapeutics develops anti-cancer agents based on the oncolytic (cancer-destroying) virus VSV-GP. VSV-GP is highly effective in all cancers tested in mouse models. VSV-GP is the only oncolytic virus so far that does not induce neutralizing (virus inactivating) antibodies and therefore can be given repeatedly without loss of efficacy. Thus, VSV-GP-therapeutics have the potential to revolutionize cancer therapy.
Team
-
Ludwig WeissDr.
CEO, co-founder, 50
-studied biology at the Ludwig-Maximilians-University in Munich
-PhD degree at the Max-Planck-Institute of Biochemistry
-Head of gene therapy research group in the Department of Virology
-18 publications in peer-reviewed journals
- Management degree, University of Augsburg
-Certified rating analyst, Standard & Poor’s
-Study of international patent and trademark law
-Management of biotech company from founding to e -
Meike Dorothee von LaerProf. Dr., MD
Initiator, co-founder, CSO, 54
- Inventor VSV-GP technology
- 1986 Medical degree
- 1986-2010 Research physician at the universities of Hamburg, Freiburg and Frankfurt
-2000 Co-founder + part-time CSO of the Vision7 GmbH, Hamburg
Currently:
-Head Division for Virology, Innsbruck Medical University
-Advisory board of the Paul-Ehrlich-Institute, German drug administration
-Review board Go-BIO funding program of German government
-over -
Lisa EgererDr.
COO, 32
Biochemist
-2009 PhD, University Frankfurt
-2010-12 Postdoc, Division of Virology, Innsbruck Medical University
-2012- COO ViraTherapeutics
-Additional training in patent law, project management and quality management
-6 publications in peer reviewed journals
- inventor for 1 patent family
Previous Investors
-
Austrian Wirtschaftsservice Pre-Seed fundingUnconfirmedCAST Pre-Seed fundingUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.